' '
Deutsch | English    

Research Database PMU-SQQUID

Publications

chosen keywordNeoadjuvant chemotherapy


Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder, SP; Peer, A; Weismann, C; Meissnitzer, M; Rinnerthaler, G; Webhofer, J; Westphal, T; Riedmann, M; Meissnitzer, T; Egger, H; Klaassen Federspiel, F; Reitsamer, R; Hauser-Kronberger, C; Stering, K; Hergan, K; Mlineritsch, B; Greil, R;
Breast Cancer Res. 2019; 21(1):19
Originalarbeiten (Zeitschrift)
Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
Vetterlein, MW; Gild, P; Kluth, LA; Seisen, T; Gierth, M; Fritsche, HM; Burger, M; Protzel, C; Hakenberg, OW; von Landenberg, N; Roghmann, F; Noldus, J; Nuhn, P; Pycha, A; Rink, M; Chun, FK; May, M; Fisch, M; Aziz, A;
BJU Int. 2018; 121(1): 101-110.
Originalarbeiten (Zeitschrift)
Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J;
Anticancer Res. 2017; 37(5):2683-2691
Originalarbeiten (Zeitschrift)
The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among Clinicians.
Martini, T; Gilfrich, C; Mayr, R; Burger, M; Pycha, A; Aziz, A; Gierth, M; Stief, CG; Muller, SC; Wagenlehner, F; Roigas, J; Hakenberg, OW; Roghmann, F; Nuhn, P; Wirth, M; Novotny, V; Hadaschik, B; Grimm, MO; Schramek, P; Haferkamp, A; Colleselli, D; Kloss, B; Herrmann, E; Fisch, M; May, M; Bolenz, C
CLIN GENITOURIN CANC. 2017; 15(3): 356-362.
Originalarbeiten (Zeitschrift)
Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011.
May, M; Fritsche, HM; Vetterlein, MW; Bastian, PJ; Gierth, M; Nuhn, P; Aziz, A; Fisch, M; Stief, CG; Hohenfellner, M; Wirth, MP; Novotny, V; Hakenberg, OW; Noldus, J; Gilfrich, C; Bolenz, C; Burger, M; Brookman-May, SD;
World J Urol. 2017; 35(2): 24-250.
Originalarbeiten (Zeitschrift)
Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.
May, M; Protzel, C; Vetterlein, MW; Gierth, M; Noldus, J; Karl, A; Grimm, T; Wullich, B; Grimm, MO; Nuhn, P; Bastian, PJ; Roigas, J; Hadaschik, B; Gilfrich, C; Burger, M; Fisch, M; Brookman-May, S; Aziz, A; Hakenberg, OW;
Int Urol Nephrol. 2017; 49(2): 247-254.
Originalarbeiten (Zeitschrift)
Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer.
Niedersüss-Beke, D; Puntus, T; Kunit, T; Grünberger, B; Lamche, M; Loidl, W; Böhm, R; Kraischits, N; Kudlacek, S; Schramek, P; Meran, JG;
Oncology. 2017; 93(1): 36-42.
Originalarbeiten (Zeitschrift)
Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy.
Houédé, N; Locker, G; Lucas, C; Parra, HS; Basso, U; Spaeth, D; Tambaro, R; Basterretxea, L; Morelli, F; Theodore, C; Lusuardi, L; Lainez, N; Guillot, A; Tonini, G; Bielle, J; Del Muro, XG;
BMC Cancer. 2016; 16(1):752
Originalarbeiten (Zeitschrift)
Chemotherapy of colorectal liver metastases induces a rapid rise in intermediate blood monocytes which predicts treatment response.
Schauer, D; Starlinger, P; Alidzanovic, L; Zajc, P; Maier, T; Feldman, A; Padickakudy, R; Buchberger, E; Elleder, V; Spittler, A; Stift, J; Pop, L; Gruenberger, B; Gruenberger, T; Brostjan, C;
Oncoimmunology. 2016; 5(6):e1160185
Originalarbeiten (Zeitschrift)
Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy Diagnostic value and the work-up of sentinel node negative patients
Dalus, K; Reitsamer, R; Holzmannhofer, J; Rendl, G; Pirich, C; Kronberger, C; Rettenbacher, L
NUKLEARMED-NUCL MED. 2011; 50(1): 33-38.
Originalarbeiten (Zeitschrift)
DNA methylation of polycomb group target genes in cores taken from breast cancer centre and periphery.
Fourkala, EO; Hauser-Kronberger, C; Apostolidou, S; Burnell, M; Jones, A; Grall, J; Reitsamer, R; Fiegl, H; Jacobs, I; Menon, U; Widschwendter, M;
BREAST CANCER RES TR. 2010; 120(2): 34-55.
Originalarbeiten (Zeitschrift)
Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.
Michlmayr, A; Bachleitner-Hofmann, T; Baumann, S; Marchetti-Deschmann, M; Rech-Weichselbraun, I; Burghuber, C; Pluschnig, U; Bartsch, R; Graf, A; Greil, R; Allmaier, G; Steger, G; Gnant, M; Bergmann, M; Oehler, R;
Br J Cancer. 2010; 103(8): 1201-1208.
Originalarbeiten (Zeitschrift)
[Neoadjuvant therapy in the upper gastro-intestinal tract. Modern strategies for Barrett"s cancer].
Stein, HJ; Feith, M; Siewert, JR;
Chirurg. 2009; 80(11):1019-1022
Übersichtsarbeiten
Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab.
Peintinger, F; Buzdar, AU; Kuerer, HM; Mejia, JA; Hatzis, C; Gonzalez-Angulo, AM; Pusztai, L; Esteva, FJ; Dawood, SS; Green, MC; Hortobagyi, GN; Symmans, WF;
Ann Oncol. 2008; 19(12):2020-2025
Originalarbeiten (Zeitschrift)
Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer.
Peintinger, F; Kuerer, HM; McGuire, SE; Bassett, R; Pusztai, L; Symmans, WF;
Br J Surg. 2008; 95(4):433-437
Originalarbeiten (Zeitschrift)
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.
Symmans, WF; Peintinger, F; Hatzis, C; Rajan, R; Kuerer, H; Valero, V; Assad, L; Poniecka, A; Hennessy, B; Green, M; Buzdar, AU; Singletary, SE; Hortobagyi, GN; Pusztai, L;
J Clin Oncol. 2007; 25(28):4414-4422
Originalarbeiten (Zeitschrift)
Blood interleukin 12 as preoperative predictor of fatal postoperative sepsis after neoadjuvant radiochemotherapy.
Novotny, AR; Emmanuel, K; Ulm, K; Bartels, H; Siewert, JR; Weighardt, H; Holzmann, B;
Br J Surg. 2006; 93(10):1283-1289
Originalarbeiten (Zeitschrift)
Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.
Peintinger, F; Kuerer, HM; Anderson, K; Boughey, JC; Meric-Bernstam, F; Singletary, SE; Hunt, KK; Whitman, GJ; Stephens, T; Buzdar, AU; Green, MC; Symmans, WF;
Ann Surg Oncol. 2006; 13(11):1443-1449
Originalarbeiten (Zeitschrift)
The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy.
Peintinger, F; Symmans, WF; Gonzalez-Angulo, AM; Boughey, JC; Buzdar, AU; Yu, TK; Hunt, KK; Singletary, SE; Babiera, GV; Lucci, A; Meric-Bernstam, F; Kuerer, HM;
Cancer. 2006; 107(6):1248-1254
Originalarbeiten (Zeitschrift)
Neoadjuvant chemotherapy in breast cancer: which diagnostic procedures can be used?
Loehberg, CR; Lux, MP; Ackermann, S; Poehls, UG; Bani, MR; Schulz-Wendtland, R; Papadopoulos, T; Schmucker, M; Beckmann, MW; Fasching, PA
ANTICANCER RES. 2005; 25(3c): 2519-2525.
Originalarbeiten (Zeitschrift)
Pathological complete response rates comparing 3 versus 6 cycles of epidoxorubicin and docetaxel in the neoadjuvant setting of patients with stage II and III breast cancer.
Reitsamer, R; Peintinger, F; Prokop, E; Hitzl, W;
ANTI-CANCER DRUG. 2005; 16(8): 86-70.
Originalarbeiten (Zeitschrift)
B7-h4 is highly expressed in ductal and lobular breast cancer.
Tringler, B; Zhuo, S; Pilkington, G; Torkko, KC; Singh, M; Lucia, MS; Heinz, DE; Papkoff, J; Shroyer, KR;
Clin Cancer Res. 2005; 11(5):1842-1848
Originalarbeiten (Zeitschrift)
Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer, R; Peintinger, F; Rettenbacher, L; Prokop, E;
J Surg Oncol. 2003; 84(2):63-67
Originalarbeiten (Zeitschrift)
Neoadjuvant chemotherapy (MVAC) in locally invasive bladder cancer.
Sagaster, P; Flamm, J; Flamm, M; Mayer, A; Donner, G; Oberleitner, S; Havelec, L; Lepsinger, L; Ludwig, H;
Eur J Cancer. 1996; 32A(8):1320-1324
Originalarbeiten (Zeitschrift)